Jinushi, Masahisa
Gilead Sciences K.K.,
Japan
2025 Rank: 207105
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 6415 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 207105 | 235928 |
| Total Cites | 369 | 381 |
| H-index | 9 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 97 | 98 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 204 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 345 | 355 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
3.15%
|
|
Jinushi, Masahisa
Gilead Sciences K.K.,
Japan
2024 Rank: 157675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5175 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157675 | 181207 |
| Total Cites | 368 | 380 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 95 | 97 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 196 | 198 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 341 | 351 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.08 |
| Self-Citation Percentage |
3.16%
|
|
Jinushi, Masahisa
AstraZeneca,
Japan
2023 Rank: 156107
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5573 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 156107 | 178883 |
| Total Cites | 381 | 398 |
| H-index | 9 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 115 | 116 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 215 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 356 | 372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
4.27%
|
|
Jinushi, Masahisa
AstraZeneca,
Japan
2022 Rank: 74145
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1792 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74145 | 86174 |
| Total Cites | 470 | 489 |
| H-index | 12 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 161 | 162 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 285 | 286 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 426 | 443 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
3.89%
|
|
Jinushi, Masahisa
Keio University School of Medicine,
Japan
2021 Rank: 81091
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1808 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81091 | 93433 |
| Total Cites | 667 | 696 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 230 | 234 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 402 | 407 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 598 | 623 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.12 |
| Self-Citation Percentage |
4.17%
|
|
Jinushi, Masahisa
AstraZeneca,
Japan
2020 Rank: 103920
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2103 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103920 | 120866 |
| Total Cites | 472 | 487 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 164 | 169 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 279 | 284 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 431 | 445 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.09 |
| Self-Citation Percentage |
3.08%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.